Skip to content
10-Q

Quarterly Report

ORAMED PHARMACEUTICALS INC. ORMP

0001213900-25-109980

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 39.8M sh
Shares Diluted Q3 2025 · Sep 30, 2025 42.77M sh
Shares Diluted Q3 2025 · Sep 30, 2025 42.97M sh
Shares Diluted Q3 2025 · Sep 30, 2024 40.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 40.88M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $732K
Stock Repurchased Q3 2025 · Sep 30, 2024 $1.29M
Capex Q3 2025 · Sep 30, 2025 $7K
Capex Q3 2025 · Sep 30, 2024 $7K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$8.68M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$6.5M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $52.18M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $54.42M
Stockholders Equity Q3 2025 · Sep 30, 2025 $203.28M
Stockholders Equity Q3 2025 · Dec 31, 2024 $146.27M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.12M
Current Liabilities Q3 2025 · Dec 31, 2024 $5.69M
Current Assets Q3 2025 · Sep 30, 2025 $136.12M
Current Assets Q3 2025 · Dec 31, 2024 $143.22M
Total Assets Q3 2025 · Sep 30, 2025 $220.49M
Total Assets Q3 2025 · Dec 31, 2024 $155.28M
Eps Diluted Q3 2025 · Sep 30, 2025 $1.13
Eps Diluted Q3 2025 · Sep 30, 2025 $1.26
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.48
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.22
Eps Basic Q3 2025 · Sep 30, 2025 $1.16
Eps Basic Q3 2025 · Sep 30, 2025 $1.30
Eps Basic Q3 2025 · Sep 30, 2024 −$0.48
Eps Basic Q3 2025 · Sep 30, 2024 −$0.22
Sga Expense Q3 2025 · Sep 30, 2025 $1.27M
Sga Expense Q3 2025 · Sep 30, 2025 $5.04M
Sga Expense Q3 2025 · Sep 30, 2024 $847K
Sga Expense Q3 2025 · Sep 30, 2024 $4.32M
Rd Expense Q3 2025 · Sep 30, 2025 $1.15M
Rd Expense Q3 2025 · Sep 30, 2025 $4.39M
Rd Expense Q3 2025 · Sep 30, 2024 $2.24M
Rd Expense Q3 2025 · Sep 30, 2024 $4.86M
Net Income Q3 2025 · Sep 30, 2025 $48.4M
Net Income Q3 2025 · Sep 30, 2025 $54.04M
Net Income Q3 2025 · Sep 30, 2024 −$19.62M
Net Income Q3 2025 · Sep 30, 2024 −$8.87M
Operating Income Q3 2025 · Sep 30, 2025 −$2.43M
Operating Income Q3 2025 · Sep 30, 2025 −$9.42M
Operating Income Q3 2025 · Sep 30, 2024 −$3.09M
Operating Income Q3 2025 · Sep 30, 2024 −$9.19M
Gross Profit Q3 2025 · Sep 30, 2025 $13K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.99M
Revenue Q3 2025 · Sep 30, 2025 $2M